Literature DB >> 26549251

Microneedling in skin of color: A review of uses and efficacy.

Brandon E Cohen1, Nada Elbuluk2.   

Abstract

In ethnic skin, traditional skin resurfacing procedures such as dermabrasion, chemical peels, and laser therapy can be effective but can also be associated with prolonged recovery and risk of complications. These complications can include a higher risk of dyspigmentation and scarring, and unsatisfactory clinical outcomes. Microneedling is an evolving treatment technique for an expanding number of dermatologic conditions. Microneedling may offer a more advantageous safety profile, particularly in the skin-of-color population (Fitzpatrick skin types IV-VI), compared with more conventional resurfacing modalities. Thus far, it has been shown to be effective for a number of dermatologic conditions in this population, including scarring, melasma, melanosis, skin rejuvenation, acne vulgaris, and primary hyperhidrosis. This article aims to provide a comprehensive review of the literature regarding the efficacy and safety of microneedling in skin of color.
Copyright © 2015 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acne vulgaris; hyperhidrosis; melasma; microneedling; scarring; skin of color: skin rejuvenation

Mesh:

Year:  2016        PMID: 26549251     DOI: 10.1016/j.jaad.2015.09.024

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  16 in total

1.  Combination Therapy Using Radiofrequency Microneedling and Corticosteroids for Hypertrophic Scars: A Case Report.

Authors:  Margit Juhasz; Nathan Fackler; Christine Pham; Natasha Atanaskova Mesinkovska
Journal:  J Clin Aesthet Dermatol       Date:  2020-12-01

2.  A Comparison of Microneedling versus Glycolic Acid Chemical Peel for the Treatment of Acne Scarring.

Authors:  Fatima Ishfaq; Rohan Shah; Shawana Sharif; Nadia Waqas; Marielle Jamgochian; Babar Rao
Journal:  J Clin Aesthet Dermatol       Date:  2022-06

Review 3.  A Comprehensive Review of Microneedling as a Potential Treatment Option for Androgenetic Alopecia.

Authors:  Lingling Jia; Jiachao Xiong; Rong Guo; Yufei Li; Hua Jiang
Journal:  Aesthetic Plast Surg       Date:  2022-08-05       Impact factor: 2.708

4.  Efficacy of Microneedling Combined With Local Application of Human Umbilical Cord-Derived Mesenchymal Stem Cells Conditioned Media in Skin Brightness and Rejuvenation: A Randomized Controlled Split-Face Study.

Authors:  Xuelei Liang; Jiaying Li; Yan Yan; Yongsheng Xu; Xiujuan Wang; Haixuan Wu; Yi Liu; Linfeng Li; Fenglin Zhuo
Journal:  Front Med (Lausanne)       Date:  2022-05-24

5.  Split-face Comparative Study of Efficacy of Platelet-rich Plasma Combined with Microneedling versus Microneedling alone in Treatment of Post-acne Scars.

Authors:  A S Nandini; Sana M Sankey; C S Sowmya; B C Sharath Kumar
Journal:  J Cutan Aesthet Surg       Date:  2021 Jan-Mar

Review 6.  Microneedling: Advances and widening horizons.

Authors:  Aashim Singh; Savita Yadav
Journal:  Indian Dermatol Online J       Date:  2016 Jul-Aug

7.  Assessment of the effects of skin microneedling as adjuvant therapy for facial melasma: a pilot study.

Authors:  Emerson V A Lima; Mariana Modesto D A Lima; Mauricio Pedreira Paixão; Hélio Amante Miot
Journal:  BMC Dermatol       Date:  2017-11-28

8.  Topical Tazarotene Gel, 0.1%, as a Novel Treatment Approach for Atrophic Postacne Scars: A Randomized Active-Controlled Clinical Trial.

Authors:  T P Afra; Muhammed Razmi T; Tarun Narang; Sunil Dogra; Ashok Kumar
Journal:  JAMA Facial Plast Surg       Date:  2019-03-01       Impact factor: 4.611

Review 9.  Melasma: an Up-to-Date Comprehensive Review.

Authors:  Oluwatobi A Ogbechie-Godec; Nada Elbuluk
Journal:  Dermatol Ther (Heidelb)       Date:  2017-07-19

10.  Unusual Presentation of Tinea Corporis Associated With the Use of a Microneedling Device.

Authors:  Nélia Margarida Martins da Cunha; Sara Leite de Azevedo Campos; Ana Isabel Pina Clemente Fidalgo
Journal:  Aesthet Surg J       Date:  2017-07-01       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.